Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection

被引:123
作者
Alberti, A [1 ]
Noventa, F [1 ]
Benvegnù, L [1 ]
Boccato, S [1 ]
Gatta, A [1 ]
机构
[1] Univ Padua, Clin Med 5, Dept Clin & Expt Med, I-35100 Padua, Italy
关键词
D O I
10.7326/0003-4819-137-12-200212170-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The prevalence of significant liver disease in persons with asymptomatic hepatitis C virus (HCV) infection is unclear. Objective: To determine the prevalence and severity of HCV infection in asymptomatic persons. Design: Population-based cross-sectional study. Setting: Northeastern Italy. Patients: 4820 apparently healthy Telecom Italy employees or their relatives who underwent screening for cardiovascular risk factors. Measurements: Initial screening for anti-HCV by enzyme-linked immunosorbent assay followed by HCV RNA testing by polymerase chain reaction and monitoring of alanine aminotransferase levels in viremic persons (92% of viremic persons also had liver biopsies to assess their METAVIR scores). Results: 116 persons (2.4% [95% Cl, 1.97% to 2.84%]) were positive for anti-HCV and 85 (1.76% [Cl, 1.39% to 2.14%]) were also viremic. The ALT level was persistently normal in 39 (46%) of viremic patients and elevated in 46 (54%). Significant hepatic histologic abnormalities were detected in 19% (Cl, 7.21% to 36.4%) of persons with persistently normal ALT levels and in 61% (Cl, 45.4% to 74.9%) of viremic persons who had elevated ALT levels (P < 0.001). The prevalence of HCV infection and number of persons with chronic liver fibrosis increased with age (P = 0.003). Conclusions: Hepatitis C is histologically active and progressive in up to 40% of asymptomatic persons with HCV infection. The severity of liver disease correlates with abnormal ALT levels and increases with age.
引用
收藏
页码:961 / 964
页数:4
相关论文
共 20 条
[1]   Natural history of hepatitis C [J].
Alberti, A ;
Chemello, L ;
Benvegnù, L .
JOURNAL OF HEPATOLOGY, 1999, 31 :17-24
[2]   ANTIBODY TO HEPATITIS-C VIRUS AND LIVER-DISEASE IN VOLUNTEER BLOOD-DONORS [J].
ALBERTI, A ;
CHEMELLO, L ;
CAVALLETTO, D ;
TAGGER, A ;
DALCANTON, A ;
BIZZARO, N ;
TAGARIELLO, G ;
RUOL, A .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (12) :1010-1012
[3]   HEPATITIS-C VIREMIA AND LIVER-DISEASE IN SYMPTOM-FREE INDIVIDUALS WITH ANTI-HCV [J].
ALBERTI, A ;
MORSICA, G ;
CHEMELLO, L ;
CAVALLETTO, D ;
NOVENTA, F ;
PONTISSO, P ;
RUOL, A .
LANCET, 1992, 340 (8821) :697-698
[4]   Hepatitis C in asymptomatic blood donors [J].
Alter, HJ ;
ConryCantilena, C ;
Melpolder, J ;
Tan, D ;
VanRaden, M ;
Herion, D ;
Lau, D ;
Hoofnagle, JH .
HEPATOLOGY, 1997, 26 (03) :S29-S33
[5]   The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States [J].
Armstrong, GL ;
Alter, MJ ;
McQuillan, GM ;
Margolis, HS .
HEPATOLOGY, 2000, 31 (03) :777-782
[6]   An algorithm for the grading of activity in chronic hepatitis C [J].
Bedossa, P ;
Poynard, T .
HEPATOLOGY, 1996, 24 (02) :289-293
[7]   Modeling the hepatitis C virus epidemic in France [J].
Deuffic, S ;
Buffat, L ;
Poynard, T ;
Valleron, AJ .
HEPATOLOGY, 1999, 29 (05) :1596-1601
[8]   HIGH-RATE OF INFECTIVITY AND LIVER-DISEASE IN BLOOD-DONORS WITH ANTIBODIES TO HEPATITIS-C VIRUS [J].
ESTEBAN, JI ;
LOPEZTALAVERA, JC ;
GENESCA, J ;
MADOZ, P ;
VILADOMIU, L ;
MUNIZ, E ;
MARTINVEGA, C ;
ROSELL, M ;
ALLENDE, H ;
VIDAL, X ;
GONZALEZ, A ;
HERNANDEZ, JM ;
ESTEBAN, R ;
GUARDIA, J .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :443-449
[9]   The dilemma of disease progression in hepatitis C patients with normal serum aminotransferase levels [J].
Hirsch, KR ;
Wright, TL .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (01) :66-67
[10]   Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial [J].
Manns, MP ;
McHutchison, JG ;
Gordon, SC ;
Rustgi, VK ;
Shiffman, M ;
Reindollar, R ;
Goodman, ZD ;
Koury, K ;
Ling, MH ;
Albrecht, JK .
LANCET, 2001, 358 (9286) :958-965